106 related articles for article (PubMed ID: 21551089)
1. CKD-MBD: comfort in the trough of the U.
Cunningham J; Silver J
Nephrol Dial Transplant; 2011 Jun; 26(6):1764-6. PubMed ID: 21551089
[No Abstract] [Full Text] [Related]
2. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.
Floege J; Kim J; Ireland E; Chazot C; Drueke T; de Francisco A; Kronenberg F; Marcelli D; Passlick-Deetjen J; Schernthaner G; Fouqueray B; Wheeler DC;
Nephrol Dial Transplant; 2011 Jun; 26(6):1948-55. PubMed ID: 20466670
[TBL] [Abstract][Full Text] [Related]
3. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study.
Naves-Díaz M; Passlick-Deetjen J; Guinsburg A; Marelli C; Fernández-Martín JL; Rodríguez-Puyol D; Cannata-Andía JB
Nephrol Dial Transplant; 2011 Jun; 26(6):1938-47. PubMed ID: 20513773
[TBL] [Abstract][Full Text] [Related]
4. Mineral and bone disease pattern in elderly haemodialysis patients.
Pelletier S; Roth H; Bouchet JL; Drueke T; London G; Fouque D;
Nephrol Dial Transplant; 2010 Sep; 25(9):3062-70. PubMed ID: 20237058
[TBL] [Abstract][Full Text] [Related]
5. Calcium and phosphorus metabolism in maintenance hemodialysis.
Ritz E; Mehls O; Krempien B
Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320
[No Abstract] [Full Text] [Related]
6. Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
Manns BJ; Hodsman A; Zimmerman DL; Mendelssohn DC; Soroka SD; Chan C; Jindal K; Klarenbach S
Am J Kidney Dis; 2010 May; 55(5):800-12. PubMed ID: 20438984
[No Abstract] [Full Text] [Related]
7. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
Mehrotra R
J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
[TBL] [Abstract][Full Text] [Related]
8. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
[TBL] [Abstract][Full Text] [Related]
9. [Chronic kidney disease (CKD) and bone. Targets of serum calcium, phosphate, and parathyroid hormone levels and their controls in maintenance dialysis patients].
Akiba T
Clin Calcium; 2009 Apr; 19(4):537-44. PubMed ID: 19329833
[TBL] [Abstract][Full Text] [Related]
10. [Arteriosclerosis and vascular calcification in chronic kidney disease (CKD) patients].
Masho Y; Shigematsu T
Clin Calcium; 2007 Mar; 17(3):354-9. PubMed ID: 17339739
[TBL] [Abstract][Full Text] [Related]
11. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.
Slinin Y; Foley RN; Collins AJ
J Am Soc Nephrol; 2005 Jun; 16(6):1788-93. PubMed ID: 15814832
[TBL] [Abstract][Full Text] [Related]
12. Mineral metabolism and mortality in patients with chronic kidney disease.
Young EW
Adv Chronic Kidney Dis; 2007 Jan; 14(1):13-21. PubMed ID: 17200039
[TBL] [Abstract][Full Text] [Related]
13. Influence of calcium infusion on calcitonin and parathyroid hormone concentrations in normal and hemodialyzed subjects.
Isaac R; Nivez MP; Piamba G; Fillastre JP; Ardaillou R
Clin Nephrol; 1975 Jan; 3(1):14-7. PubMed ID: 1126058
[TBL] [Abstract][Full Text] [Related]
14. Mineral metabolism disturbances in patients with chronic kidney disease.
Kestenbaum B; Belozeroff V
Eur J Clin Invest; 2007 Aug; 37(8):607-22. PubMed ID: 17635571
[TBL] [Abstract][Full Text] [Related]
15. [Biochemical changes in patients with chronic renal insufficiency during hemodialysis depending on whether or not they received 25-(OH)D3].
Rico H; Naranjo P; Paniagua MC; Cordero M; Bordiu E; Charro A
Rev Clin Esp; 1982 Oct; 167(1):45-7. PubMed ID: 7178586
[No Abstract] [Full Text] [Related]
16. [Parathyroidectomy in secondary hyperparathyroidism in chronic uremic patients under dialysis treatment. Development of the surgical strategy].
Zucchi C
Minerva Med; 1985 Mar; 76(9-10):397-401. PubMed ID: 3982697
[No Abstract] [Full Text] [Related]
17. Variability in calcium, phosphorus, and parathyroid hormone in patients on hemodialysis.
Levitt H; Smith KG; Rosner MH
Hemodial Int; 2009 Oct; 13(4):518-25. PubMed ID: 19758299
[TBL] [Abstract][Full Text] [Related]
18. [Parathyroid hormone values in patients on chronic dialysis treatment].
Mushmov D; Milkov V; Kiriakov Z; Zakharieva B
Vutr Boles; 1986; 25(3):59-62. PubMed ID: 3765580
[TBL] [Abstract][Full Text] [Related]
19. Adherence to K/DOQI practice guidelines for bone metabolism and disease.
Hoy T; Fisher M; Barber B; Borker R; Stolshek B; Goodman W
Am J Manag Care; 2007 Nov; 13(11):620-5. PubMed ID: 17988187
[TBL] [Abstract][Full Text] [Related]
20. Mineral metabolism and mortality in dialysis patients: a reassessment of the K/DOQI guideline.
Noordzij M; Korevaar JC; Dekker FW; Boeschoten EW; Bos WJ; Krediet RT; Bossuyt PM; Geskus RB;
Blood Purif; 2008; 26(3):231-7. PubMed ID: 18305386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
